Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:de Herder W" with an ORCID

Wouter de Herder
No affiliation detected
23
Publications
1,315
Citations
View profile

Search results

1-25 of 532 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Clinicopathological and epigenetic differences between primary neuroendocrine tumors and neuroendocrine metastases in the ovary.
Mulders MC, Verschuur AVD, de Lussanet de la Sablonière QG, Roes EM, Geisenberger C, Brosens LA, de Herder WW, van Velthuysen MF, Hofland J
J Pathol Clin Res, 10(6):e70000, 01 Nov 2024
Cited by: 0 articles | PMID: 39513463 | PMCID: PMC11544441
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Ovarian neuroendocrine tumor metastases can induce estrogen production in postmenopausal patients.
Mulders MCF, van Velthuysen MF, Roes EM, Hofland LJ, Sasano H, de Herder WW, Hofland J
Eur J Endocrinol, 191(1):K1-K4, 01 Jul 2024
Cited by: 0 articles | PMID: 38917055
Add to export list
[¹⁷⁷Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study.
Singh S, Halperin D, Myrehaug S, Herrmann K, Pavel M, Kunz PL, Chasen B, Tafuto S, Lastoria S, Capdevila J, García-Burillo A, Oh DY, Yoo C, Halfdanarson TR, Falk S, Folitar I, Zhang Y, Aimone P, de Herder WW, [...] all the NETTER-2 Trial Investigators
Lancet, 403(10446):2807-2817, 05 Jun 2024
Cited by: 10 articles | PMID: 38851203
Add to export list
Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET.
Singh S, Ferone D, Capdevila J, Chan JA, de Herder WW, Halperin D, Mailman J, Hellström L, Liedman H, Svedberg A, Tiberg F
Trials, 25(1):297, 02 May 2024
Cited by: 0 articles | PMID: 38698434 | PMCID: PMC11064387
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators.
Mulders MCF, de Herder WW, Hofland J
Endocr Rev, 45(3):351-360, 01 May 2024
Cited by: 1 article | PMID: 38038364 | PMCID: PMC11074795
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Glucagon and insulin: 100 years young.
de Herder WW, Klöppel G
Endocr Relat Cancer, 31(5):e230345, 16 Apr 2024
Cited by: 0 articles | PMID: 38631379
Add to export list
Approach to the Patient: Insulinoma.
Hofland J, Refardt JC, Feelders RA, Christ E, de Herder WW
J Clin Endocrinol Metab, 109(4):1109-1118, 01 Mar 2024
Cited by: 6 articles | PMID: 37925662 | PMCID: PMC10940262
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN.
Blay JY, Casali P, Ray-Coquard I, Seckl MJ, Gietema J, de Herder WW, Caplin M, Klümpen HJ, Glehen O, Wyrwicz L, Peeters R, Licitra L, Girard N, Piperno-Neumann S, Kapiteijn E, Idbaih A, Franceschi E, Trama A, Frezza AM, [...] Weinman A
Lancet Reg Health Eur, 39:100861, 16 Feb 2024
Cited by: 0 articles | PMID: 38384730 | PMCID: PMC10879812
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET.
Singh S, Ferone D, Capdevila J, Chan JA, de Herder WW, Halperin D, Mailman J, Hellström L, Liedman H, Svedberg A, Tiberg F
Trials, 25(1):58, 16 Jan 2024
Cited by: 1 article | PMID: 38229199 | PMCID: PMC10790497
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature.
Mulders MCF, Audhoe AS, Van Koetsveld PM, Feelders RA, Hofland LJ, de Herder WW, Kraaij R, Hofland J
Eur J Cancer, 197:113472, 09 Dec 2023
Cited by: 1 article | PMID: 38100919
Add to export list
Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours.
Jørgensen JOL, de Herder WW, Martin WA, Kolarova T, Marks M, Follin C, Geilvoet W, Melmed S
Adv Ther, 40(10):4675-4688, 12 Aug 2023
Cited by: 0 articles | PMID: 37573277
Add to export list
One hundred years after the discovery of insulin and glucagon: the history of tumors and hyperplasias that hypersecrete these hormones.
de Herder WW, Klöppel G
Endocr Relat Cancer, 30(9):e230046, 28 Jul 2023
Cited by: 2 articles | PMID: 37310813
Add to export list Review
A bronze statue of the acromegalic giant Rigardus Rijnhout
de Herder W
J Endocrinol Invest, 47(3):757-758, 17 Jun 2023
Cited by: 0 articles | PMCID: PMC10904497
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST.
de Mestier L, Resche-Rigon M, Dromain C, Lamarca A, La Salvia A, de Baker L, Fehrenbach U, Pusceddu S, Colao A, Borbath I, de Haas R, Rinzivillo M, Zerbi A, Funicelli L, de Herder WW, Selberherr A, Wagner AD, Manoharan P, De Cima A, [...] Vullierme MP
J Neuroendocrinol, 35(6):e13311, 21 Jun 2023
Cited by: 0 articles | PMID: 37345276
Add to export list
Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors.
Mulders MCF, de Lussanet de la Sablonière QG, van Velthuysen MLF, Roes EM, Hofland J, de Herder WW
Endocr Relat Cancer, 30(8):e230035, 26 Jun 2023
Cited by: 0 articles | PMID: 37140986
Add to export list
Neuropathic foot ulcers in the tallest patients with acromegalic gigantism: a common and significant problem. Historical overview.
de Herder WW, Raymond WA
Pituitary, 26(4):333-339, 04 Jun 2023
Cited by: 0 articles | PMID: 37270760 | PMCID: PMC10397114
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN survey.
Hernando J, Kolarova T, Verslype C, Kaltsas G, Houchard A, Gueguen D, De Herder WW
J Neuroendocrinol, 35(6):e13281, 08 Jun 2023
Cited by: 3 articles | PMID: 37290479
Add to export list
Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion.
Trivellin G, Daly AF, Hernández-Ramírez LC, Araldi E, Tatsi C, Dale RK, Fridell G, Mittal A, Faucz FR, Iben JR, Li T, Vitali E, Stojilkovic SS, Kamenicky P, Villa C, Baussart B, Chittiboina P, Toro C, Gahl WA, [...] Stratakis CA
Front Endocrinol (Lausanne), 14:1166076, 14 Jun 2023
Cited by: 4 articles | PMID: 37388215 | PMCID: PMC10303134
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Effective strategies for adequate control of hormonal secretion in functioning neuroendocrine neoplasms.
Hofland J, de Herder WW
Best Pract Res Clin Endocrinol Metab, 37(5):101787, 07 Jun 2023
Cited by: 3 articles | PMID: 37311669
Add to export list Review
The Driver Role of Pathologists in Endocrine Oncology: What Clinicians Seek in Pathology Reports.
Ezzat S, de Herder WW, Volante M, Grossman A
Endocr Pathol, 34(4):437-454, 11 May 2023
Cited by: 2 articles | PMID: 37166678 | PMCID: PMC10733199
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Epigenetic regulation of SST₂ expression in small intestinal neuroendocrine tumors.
Klomp MJ, Refardt J, van Koetsveld PM, Campana C, Dalm SU, Dogan F, van Velthuysen MF, Feelders RA, de Herder WW, Hofland J, Hofland LJ
Front Endocrinol (Lausanne), 14:1184436, 08 May 2023
Cited by: 2 articles | PMID: 37223009 | PMCID: PMC10200989
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Proteomic analysis of small intestinal neuroendocrine tumors and mesenteric fibrosis.
Blažević A, Iyer AM, van Velthuysen MF, Hofland J, Franssen GJH, Feelders RA, Zajec M, Luider TM, de Herder WW, Hofland LJ
Endocr Relat Cancer, 30(6):e220237, 11 May 2023
Cited by: 2 articles | PMID: 36951556
Add to export list
The science behind the relations among cancer, height, growth patterns, and growth hormone axis.
Boguszewski CL, Boguszewski MCDS, de Herder WW
Endocr Relat Cancer, 30(4):e220400, 10 Mar 2023
Cited by: 0 articles | PMID: 36779772
Add to export list Review
Germline loss-of-functionPAMvariants are enriched in subjects with pituitary hypersecretion
Trivellin G, Daly AF, Hernández-Ramírez LC, Araldi E, Tatsi C, Dale RK, Fridell G, Mittal A, Faucz FR, Iben JR, Li T, Vitali E, Stojilkovic SS, Kamenicky P, Villa C, Baussart B, Chittiboina P, Toro C, Gahl WA, [...] Stratakis CA
medRxiv, 20 Jan 2023
Cited by: 0 articles | PPR: PPR599724
Add to export list Preprint
Efficacy and safety of peptide receptor radionuclide therapy with [¹⁷⁷Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma.
Minczeles NS, Bos EM, de Leeuw RC, Kros JM, Konijnenberg MW, Bromberg JEC, de Herder WW, Dirven CMF, Hofland J, Brabander T
Eur J Nucl Med Mol Imaging, 50(4):1195-1204, 01 Dec 2022
Cited by: 6 articles | PMID: 36454268
Add to export list

1-25 of 532 results

1 2 3 Next ...

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:de Herder W" with an ORCID

Search results

Clinicopathological and epigenetic differences between primary neuroendocrine tumors and neuroendocrine metastases in the ovary.

Ovarian neuroendocrine tumor metastases can induce estrogen production in postmenopausal patients.

[¹⁷⁷Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study.

Correction: Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET.

What Is Carcinoid Syndrome? A Critical Appraisal of Its Proposed Mediators.

Glucagon and insulin: 100 years young.

Approach to the Patient: Insulinoma.

Management of patients with rare adult solid cancers: objectives and evaluation of European reference networks (ERN) EURACAN.

Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NET.

Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signature.

Key Device Attributes for Injectable Somatostatin Receptor Ligand Therapy in Acromegaly and Neuroendocrine Tumours.

One hundred years after the discovery of insulin and glucagon: the history of tumors and hyperplasias that hypersecrete these hormones.

A bronze statue of the acromegalic giant Rigardus Rijnhout

Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST.

Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors.

Neuropathic foot ulcers in the tallest patients with acromegalic gigantism: a common and significant problem. Historical overview.

Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN survey.

Germline loss-of-function PAM variants are enriched in subjects with pituitary hypersecretion.

Effective strategies for adequate control of hormonal secretion in functioning neuroendocrine neoplasms.

The Driver Role of Pathologists in Endocrine Oncology: What Clinicians Seek in Pathology Reports.

Epigenetic regulation of SST₂ expression in small intestinal neuroendocrine tumors.

Proteomic analysis of small intestinal neuroendocrine tumors and mesenteric fibrosis.

The science behind the relations among cancer, height, growth patterns, and growth hormone axis.

Germline loss-of-functionPAMvariants are enriched in subjects with pituitary hypersecretion

Efficacy and safety of peptide receptor radionuclide therapy with [¹⁷⁷Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma.

Partnerships & funding

Search life-sciences literature (45,100,050 articles, preprints and more)

Suggested authors matching "AUTH:de Herder W" with an ORCID Suggested authors have linked their articles in Europe PMC to their ORCID iD. Up to two suggested authors with a matching surname and initial are shown, ordered by the total number of publications they have in Europe PMC.

Search results

Partnerships & funding

Suggested authors matching "AUTH:de Herder W" with an ORCID